|
On
September 21-22, 2004
, NIH OBA held a safety symposium in conjunction with the
meeting of the Recombinant DNA Advisory Committee (RAC). The
symposium addressed safety considerations for recombinant DNA
research with pathogenic viruses, focusing on containment issues
for research with such viruses as 1918 influenza virus, highly
pathogenic avian influenza viruses, and SARS Co-V.
A major goal of the symposium was to develop a Points to Consider
document and other resources to assist IBCs in conducting risk
assessments and determining appropriate containment. |
|
